October 25, 2003 - Volume 25 - Issue 20
pp: 4-71
Subscribe to eTOC





Tidal Wave of Bureaucracy Poised to Swamp European Research, Conference Told

Smith, Michael

Oncology Times . 25(20):20,23, October 25, 2003.

News of note from the European Cancer Conference: Docetaxel is apparent winner in first head-to-head comparison with paclitaxel, but toxicity much greater; first gold-standard NSCLC comparison trial proves adjuvant chemo extends survival; Richard Peto's assessment that fewer men are dying of prostate cancer, thanks to hormone therapy; and the tidal wave of paperwork predicted to swamp European research.